7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal

7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal Letter (1625) Total Article Views Authors: Kapoor S Published Date May 2012 Volume 2012:3 Pages 15 - 16 DOI: http://dx.doi.org/10.2147/JBM.S31988 Received: 20 March 2012 Accepted: 20 March 2012 Published: 09 May 2012 Shailendra Kapoor Richmond, VA, USA I read with great interest the paper by Jin et al in a recent issue of your journal.1 The article is highly thought-provoking. Interestingly, the past few years have also seen the emergence of nitric oxide synthetase inhibitors, especially 7-nitroindazole, as novel new agents with significant benefits in opioid pain management and withdrawal. View original paper by Jin and Loscalzo. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors Fructose-enhanced reduction of bacterial growth on nanorough surfaces A self-assembling peptide RADA16-I integrated with spider fibroin uncrystalline motifs The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability Enhancing the specificity and efficiency of polymerase chain reaction using polyethyleneimine-based derivatives and hybrid nanocomposites In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab